Trends in Glycoscience and Glycotechnology
Online ISSN : 1883-2113
Print ISSN : 0915-7352
ISSN-L : 0915-7352
MINIREVIEW
Application toward Drug Delivery System Using β-1,3-Glucan
Yoshiya MaegawaShinichi MochizukiNoriko MiyamotoYusuke SanadaKazuo Sakurai
Author information
JOURNAL FREE ACCESS

2015 Volume 27 Issue 153 Pages 13-29

Details
Abstract
A β-1,3-D-glucan called Schizophyllan (SPG) can form a novel complex with homo oligodeoxynucleotides (ODNs) via the combination of hydrogen bonding and hydrophobic interactions. Dectin-1 is a major receptor involved in the recognition of β-1,3-D-glucans and expressed on antigen presenting cells (APCs) including macrophages, dendritic cells, monocytes, neutrophils, and a subset of T cells. Therefore, the SPG/ODN complex can be used as APCs cell-specific delivery of antisense ODNs (AS-ODNs) or unmethylated CpG sequences (CpG-ODNs). In fact, AS-ODN/SPG complex protected mice from LPS-induced hepatitis and CpG-ODN/SPG complex induced high antibody titers when it was administered to cynomolgus monkeys as adjutant of influenza vaccine. These results indicate that SPG can be an excellent drug delivery system carrier targeting APCs.
Content from these authors
© 2015 FCCA(Forum: Carbohydrates Coming of Age)
Previous article Next article
feedback
Top